In severe, uncontrolled asthma, tezepelumab reduced exacerbations over 1 y regardless of type 2 inflammation level

Producción científica: Comment/debate › revisión exhaustiva

ASJC Scopus subject areas

@article{7832ac50ae4642ce93f565a309184685,

title = "In severe, uncontrolled asthma, tezepelumab reduced exacerbations over 1 y regardless of type 2 inflammation level",

author = "Estrada, \{Rodolfo A.\} and Maselli, \{Diego J.\}",

year = "2023",

month = nov,

day = "1",

doi = "10.7326/J23-0084",

language = "English (US)",

volume = "176",

pages = "JC128",

journal = "Annals of internal medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

number = "11",

}

TY - JOUR

T1 - In severe, uncontrolled asthma, tezepelumab reduced exacerbations over 1 y regardless of type 2 inflammation level

AU - Estrada, Rodolfo A.

AU - Maselli, Diego J.

PY - 2023/11/1

Y1 - 2023/11/1

UR - https://www.scopus.com/pages/publications/85178540092

UR - https://www.scopus.com/pages/publications/85178540092#tab=citedBy

U2 - 10.7326/J23-0084

DO - 10.7326/J23-0084

M3 - Comment/debate

C2 - 37931261

AN - SCOPUS:85178540092

SN - 0003-4819

VL - 176

SP - JC128

JO - Annals of internal medicine

JF - Annals of internal medicine

IS - 11

ER -